Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Eli Lilly and Company Foundation has announced additional funds worth $30m to help the Lilly MDR-TB Partnership combat multidrug- resistant tuberculosis.
Subscribe to our email newsletter
Initially, Lilly committed $70m to launch the partnership, to fight against multidrug-resistant tuberculosis (MDR-TB) and transfer technology for two Lilly medicines used to treat MDR- TB to other manufacturers.
The additional $30m will help provide training for healthcare providers and improve supply and access to safe, effective and quality-assured second-line drugs.
The company will have committed a total of $165m from 2003-2016 in cash, product and in-kind services and material to The Lilly MDR-TB Partnership and external early drug discovery efforts for TB.